Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Synta Pharmaceuticals Corp (NASDAQ:SNTA)

1.98
Delayed Data
As of Aug 27
 +0.12 / +6.45%
Today’s Change
1.75
Today|||52-Week Range
4.12
-25.28%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues7.6M0.000.000.00
 
 
Depreciation And Amortization1.5M738.0K516.0K673.0K
 
 
 
 
 
 
Operating ExpensesGross Income6.1M---516.0K-673.0K
 
 
 
 
General Expenses51.6M60.4M87.0M83.3M
 
 
 
 
 
Research And Development41.5M49.4M71.9M68.2M
 
 
 
 
 
Total Operating Expenses53.0M61.1M87.6M84.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-45.4M-61.1M-87.6M-84.0M
 
 
 
 
 
Interest Expense On Debt1.9M1.8M2.6M2.2M
 
 
 
 
 
Other Expenses0.00147.0K0.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-47.4M-62.8M-90.2M-86.2M
 
 
 
 
 
Net Income-47.4M-62.8M-90.2M-86.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS47.2M59.4M71.0M98.5M
 
 
 
 
 
Shares To Calculate EPS Diluted47.2M59.4M71.0M98.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.00-$1.06-$1.27-$0.87
 
 
 
 
 
EPS Diluted-$1.00-$1.06-$1.27-$0.87